Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Why it matters: Novo has filed several lawsuits against compounders over false advertising and trademark claims, but this marks its first suit against Hims, and its first patent case
Top vendors hit 99% or better
Takase T, Nakamura A, Yamamoto C, et al
GLP-1R agonists and perioperative outcomes 1
Glucagon-like peptide-1 receptor agonists and dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonists in the treatment of obesity/metabolic syndrome, prediabetes/diabetes and non-alcoholic fatty liver disease-current evidence
Diabetes Obes Metab 20(3):571581
US$ 28.99
US$ 23.91
US$ 21.34
US$ 29.46
US$ 25.82
